Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAnglo American Regulatory News (AAL)

Share Price Information for Anglo American (AAL)

Share Price is delayed by 15 minutes
Get Live Data
4,043.00    -63.00 (-1.53%)
Bid:
4,042.00
Ask:
4,044.00
Spread: 2.00 (0.049%)
Market Cap: £43.32b
AAL Live PriceLast checked at - London Stock Exchange

Intraday Anglo American Share Chart

Form 8.3 - Anglo American plc

8 May 2024 07:19

RNS Number : 5729N
Superannuation and Inv. HoldCo Pty
08 May 2024
Β 

FORM 8.3

Β 

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the "Code")

Β 

1. KEY INFORMATION

Β 

(a) Full name of discloser:

Superannuation and Investments HoldCo Pty Ltd

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Anglo American plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

Dealing disclosure

03/05/2024

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state "N/A"

Yes, BHP Group Limited

Β 

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

Β 

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

Β 

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Β 

Class of relevant security:

Β 

USD 0.54945 ordinary (ISIN: GB00B1XZS820)

Β 

Β 

Interests

Short positions

Β 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

594,930

0.044

0

0.00

(2) Cash-settled derivatives:

Β 

0

0.000

0

0.00

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

0

0.000

0

0.00

Β 

TOTAL:

594,930

0.044

0

0.00

Β 

All interests and all short positions should be disclosed.

Β 

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental FormΒ 8 (Open Positions).

Β 

(b) Rights to subscribe for new securities (including directors' and other employee options)

Β 

Class of relevant security in relation to which subscription right exists:

Β 

Details, including nature of the rights concerned and relevant percentages:

Β 

Β 

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Β 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

Β 

The currency of all prices and other monetary amounts should be stated.

Β 

(a) Purchases and sales

Β 

Class of relevant security

Purchase/sale

Β 

Number of securities

Price per unit

USD 0.54945 ordinary

Purchase

34,595

GBP 27.04559994

USD 0.54945 ordinary

Purchase

11,500

GBP 27.5629

Β 

Β 

(b) Cash-settled derivative transactions

Β 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

Β 

Β 

Β 

(c) Stock-settled derivative transactions (including options)

Β 

(i) Writing, selling, purchasing or varying

Β 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

Β 

(ii) Exercise

Β 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

Β 

Β 

Β 

Β 

Β 

Β 

Β 

(d) Other dealings (including subscribing for new securities)

Β 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

Β 

Β 

Β 

Β 

Β 

Β 

Β 

4. OTHER INFORMATION

Β 

(a) Indemnity and other dealing arrangements

Β 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(b) Agreements, arrangements or understandings relating to options or derivatives

Β 

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

Β 

None

Β 

Β 

(c) Attachments

Β 

Is a Supplemental Form 8 (Open Positions) attached?

NO

Β 

Β 

Date of disclosure:

08/05/2024

Contact name:

Β 

Anna Wyke

Telephone number*:

+61 2 9197 3050

Β 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

Β 

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

Β 

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel's Market Surveillance Unit.

Β 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

Β 

* This report is on behalf of:

Β 

Colonial First State Investments Limited

Avanteos Investments Limited

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
RETEAKSPEFPLEEA
Date   Source Headline
1st Apr 20251:00 pmRNSTotal Voting Rights
28th Mar 20252:00 pmRNSDirector/PDMR Shareholding
26th Mar 20252:00 pmRNSDirector/PDMR Shareholding
25th Mar 202511:00 amRNSDirector/PDMR Shareholding
25th Mar 202510:45 amRNSSakatti awarded ‘Strategic Project’ status
24th Mar 20259:00 amRNSNotice of AGM
18th Mar 202511:00 amRNSDirector/PDMR Shareholding
13th Mar 20258:00 amRNSMogalakwena achieves IRMA 50
12th Mar 20255:26 pmRNSPricing of USD and Euro Tender Offer
12th Mar 202512:00 pmRNSResult of Tender Offer
7th Mar 20253:00 pmRNSDirector/PDMR Shareholding
6th Mar 202510:00 amRNSDirector Declaration
5th Mar 20252:00 pmRNSDirector/PDMR Shareholding
3rd Mar 20251:00 pmRNSTotal Voting Rights
3rd Mar 20259:00 amRNSAnnual Financial Report
27th Feb 20252:00 pmRNSHolding(s) in Company
26th Feb 20253:00 pmRNSDirector/PDMR Shareholding
26th Feb 202512:00 pmRNSAnglo American announces Tender Offer
25th Feb 20251:35 pmRNSDe Beers and Botswana sign diamond partnership
20th Feb 20257:01 amRNSAnglo American signs MoU with Codelco
20th Feb 20257:00 amRNSAnglo American full year 2024 Results
18th Feb 20257:00 amRNSAnglo American agrees sale of nickel business
18th Feb 20257:00 amRNSKumba Iron Ore 2024 year end results
17th Feb 20257:00 amRNSAnglo American update on AAP demerger
6th Feb 20257:00 amRNSAnglo American Production Report Q4 2024
3rd Feb 20252:00 pmRNSTotal Voting Rights
29th Jan 20257:00 amRNSAnglo American completes sale of Jellinbah
22nd Jan 202511:30 amRNSHolding(s) in Company
2nd Jan 20251:00 pmRNSTotal Voting Rights
23rd Dec 202412:00 pmRNSProvisional 2025 Dividend Timetable
20th Dec 202411:00 amRNSDirector/PDMR Shareholding
18th Dec 20243:00 pmRNSDirector/PDMR Shareholding
10th Dec 20248:00 amRNSAnglo American appoints Anne Wade as NED
3rd Dec 20247:00 amRNSAnglo American completes Serpentina transaction
2nd Dec 20243:30 pmRNSTotal Voting Rights
27th Nov 20247:00 amRNSResults of bookbuild offering of shares in AAP
26th Nov 20243:20 pmRNSLaunch of bookbuild offering of shares in AAP
25th Nov 20247:00 amRNSAnglo American to sell steelmaking coal business
18th Nov 20243:00 pmRNSDirector/PDMR Shareholding
4th Nov 20247:00 amRNSAngloAmerican agrees sale of interest in Jellinbah
1st Nov 20242:00 pmRNSTotal Voting Rights
1st Nov 202412:00 pmRNSDirector Declaration
29th Oct 202411:17 amRNSAnglo American highlights role of sustainability
28th Oct 20243:00 pmRNSDirector/PDMR Shareholding
24th Oct 20247:00 amRNSAnglo American Production Report Q3 2024
16th Oct 20243:00 pmRNSDirector/PDMR Shareholding
14th Oct 202411:30 amRNSResults of Dividend Reinvestment Plan
8th Oct 20243:00 pmRNSDirector/PDMR Shareholding
2nd Oct 20244:00 pmRNSDirector/PDMR Shareholding
1st Oct 20242:00 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.